Trial intelligence / Profile preview

Phase 2b randomized double-blind placebo-controlled study of BJY-802 in stable angina

CTR20201387Phase 2Active

Sponsor
八加一药业
Start
Jul 2020
Countries
1
01

Overview

A Phase 2 trial of BJY-802 in stable angina, coronary arteriosclerosis, sponsored by 八加一药业. Started Jul 2020; status: active.

02

Drugs

BJY-802
03

Conditions

stable anginacoronary arteriosclerosis

Beyond the preview

Go deeper on CTR20201387.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20201387.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call